VEGFR-1/2 peptide vaccine (Keio University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVEGFR-1/2 peptide vaccine (Keio University)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionVascular endothelial growth factor receptor 1 antagonistsVascular endothelial growth factor receptor 2 antagonists

TargetsVascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 2

Therapy Area/IndicationsBrain NeoplasmsNeurofibromatosesGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesKeio University

China Registration ClassN/A

Active CompaniesKeio University

Inactive CompaniesN/A

Active IndicationsBrain NeoplasmsNeurofibromatosesGlioma

Inactive IndicationsN/A

ATC CodeN/A